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The topical application of thorium X was introduced into dermatologic
therapy in 1913 (6), and has been in use since that time. Its biological effective-
ness has been repeatedly demonstrated both clinically (3, 6, 7, 9, 11, 12, 13, 14)
and histopathologically (4, 5, 6, 8).
The erythema effect of thorinm X on human skin is largely due to alpha radia-
tion, although some is due to the small amount of beta and gamma radiation
emitted. Lomholt (4) was the first to demonstrate this effect of the alpha par-
ticles. This was accomplished by applying thorium X solution to the surface of a
layer of gutta pereha sufficiently thick to absorb the alpha rays and allow only
the beta and gamma radiation to pass through. Each time this experiment was
repeated a marked reduction in the usual erythema resulted.
This simple but impressive demonstration of the biologic effectiveness of the
alpha particles of topically applied thorium X received scant notice for many
years thereafter. It was believed that, because this type of radiation could be
stopped with a thin sheet of paper, it could not penetrate the epidermis and
consequently could not produce biologic effects.
In considering the mechanisms which might explain the biologic effectiveness
of topically applied thorium X, it is necessary to take into account the form in
which the alpha radiation contacts the skin. When thorium X is applied in a
vehicle such as alcohol it is carried into the epidermis and its appendages, thus
permitting the alpha radiation to bombard the skin intensely from without and
within (15, 16). This is in contrast to the application of thorium X in plaque
form, which allows the alpha particles to bombard the skin from the surface
only. In the latter instance the erythema effect is markedly less than that pro-
duced by an equal amount of thorium X applied to the surface of the skin in
alcoholic solution (17).
In view of the findings that alpha rays are capable of producing a biologic
effect on human skin even when they bombard it only from the surface, and
because these findings are contrary to common belief, the present study was
undertaken to clarify further the phenomena concerned. For our purpose, we
selected polonium210 in the form of a sealed plaque, thus permitting irradiation
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of the skin from the surface with a pure alpha emitter. In preliminary studies,
Earle W. Brauer and one of us (V.H.W.) demonstrated that erythema of human
skin could be produced with a polonium plaque if adequate doses were given.
Description of the sources and their calibration
Special polonium plaques were prepared by a commercial supplier. * These
plaques consisted of a nickel disc, 1 cm in diameter and approximately 1 mm
thick, on one face of which the polonium was plated. The active deposit covered
the entire face of the disc. Approximately 1 micron of pure gold was plated on
top of the polonium. Two such plaques were prepared containing approximately
10 and 15 mc of polonium each. Preparatory studies were performed with the
first, on which the active deposit was found to be quite non-uniform. The present
reported work was done with the second plaque, which was shown by auto-
radiographic studies to have a relatively uniform distribution of the polonium.
The radioactive isotope of polonium used here was 54Po' (RaF). It has a
half-life of 138 days, and emits only alpha particles of 5.3 Mev energy. It is
obtained essentially free of contamination with any other radioactive material.
The gold is plated on the polonium in order to reduce the loss of polonium
from the surface of the nickel disc. The gold covering must be made very thin,
for if it is too thick it will absorb the emitted alpha particles completely. As a
result of the very thin and perhaps irregular plating of gold there is some leaking
of the polonium atoms through the gold. Since small amounts of ingested polo-
nium210 are potentially harmful, it is necessary to handle the plaques with care
to avoid contamination. The polonium plaque used in the present study was in
all instances wrapped in one layer of 25 gauge Mylar film.t After each use the
plastic film was discarded.
The polonium plaques were calibrated with an extrapolation chamber, which
has been described elsewhere (2). This ionization chamber can be set to very
thin air gaps, making it suitable for the measurement of alpha particle sources.
The thin electrode on one side of the extrapolation chamber consists of 25 gauge
Mylar film. When calibrating the plaques, the active surface was brought into
contact with this thin electrode. Thus, the "surface" dose rate measured by the
extrapolation chamber corresponded to that at the surface of the skin, since the
thin electrode attenuated the alpha radiation to the same extent as the film
wrapped around the polonium source when it was applied to the skin of the
human volunteers.
The average surface dose rate of the polonium plaque used for the present
* Canadian Radium and Uranium Corporation, New York, N. Y.
t The International Commission on Radiological Protection gives 0.02 pc as the maximum
permissible amount of polonium210 in the human body (1).
t "Mylar" is the trade name of a DuPont polyester film made from poly-
ethylene terephthalate. It is a tough, flexible, and highly impermeable plastic material.
While it is available in a range of thicknesses, the thinnest film (25 gauge) is 0.00025 incbes,
or 0.0064 mm thick. This is found by measurement to equal 0.9 mg/cm2, which indicates





























FIG. 1. Depth-dose curves for polonium and thorium X plaques, within the alpha-particle
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Fm. 2. Depth-dose curves for polonium and thorium X plaques, beyond tile end of the
alpha-particle range. The logarithm of the depth-dose relative to 100% at the surface is
plotted against absorber thickness in mg/cm2.
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study was found to be 300,000 rad* per minute, on the reference date. The dose
rate on subsequent days (for a period of about two months) was computed using
the half-life of 138 days.
The extrapolation chamber also served to measure the relative depth dose of
the radiation from the plaque, using Mylar film as the absorber. The results are
shown in Figures 1 and 2. The depth dose of the alpha particles from the polonium
plaque is shown in Figure 1 to decrease linearly with absorber thickness. This
result is expected from theoretical considerations (10). The same figure gives the
relative depth dose measured on a similar thorium X plaque. By way of con-
trast, the thorium X curve is distinctly non-linear, since the alpha particles of
thorium X and its daughter products are emitted with the beta particles of
Th B, Th C, and Tb C", as well as with the gamma rays of Tb C".
The relative depth dose of the two plaques, beyond the end of the alpha par-
ticle range, is shown in Figure 2. The polonium plaque has a relative dose of
only 0.0002% of the surface dose, at a depth of 7 mg/cm2, dropping to o of
that value at 20 mg/cm2. Again by way of contrast, the thorium X has a relative
dose of 0.7 % and 0.2% at 7 and 20 mg/cm2 depth, respectively.
In interpreting Figures 1 and 2, it is assumed that 1 mg/cm of Mylar film is,
in absorption, equivalent to 10 microns of tissue thickness. This comes about as
follows: The absorption of alpha particles in all material of low atomic number
(air, plastic, water, tissue, etc.) is approximately the same, provided the thick-
ness is measured in mass units (e.g. mg/cm2). Thus, 1 mg/cm2 of plastic film is
equivalent in absorption to 1 mg/cm2 of tissue. Since tissue has a specific gravity
very close to 1 gm/cm3, it follows that absorption in 1 cm of tissue thickness
1000 mg/cm2, and hence 1 mg/cm2 = absorption in 10 microns of tissue thick-
ness.
From these considerations, it is concluded that a dose of one million rad to
the skin surface would deliver only about 2.0 and 0.1 rad at depths of 70 and
200 microns, respectively. The same surface dose from a thorium X plaque would
deliver a dose at these depths 3000 to 10,000 times larger. From the known
absence of sequelae for thorium X (7, 9, 11, 12, 13, 14), it was concluded that a
surface dose up to one million rad from the polonium plaque would be safe.
EXPERIMENT 1
Procedure
This experiment was designed to ascertain whether or not alpha radiation
from a solid polonium plaque applied to the surface of the skin would regularly
produce erythema.
The subjects used for this study were 5 healthy white males between the ages
of 23 and 39 years. The polonium plaque was applied to the skin on the flexor
aspect of the right arm. The sites to be irradiated were located in a linear fashion
along the long axis of the arm and were spaced so the center of each was 2.5 to
* 1 rad equals 100 ergs of absorbed energy per gram. This is approximately equivalent
to 1 rep or 1 roentgen.
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3 cm from the center of the adjacent site. The surface doses were 23, 55, 110
and 660 kilorad.
In order to avoid contamination of the skin by the polonium plaque it was
covered with a sheet of 25 gauge Mylar film. Before and following each appli-
cation, smears of the covering Mylar were taken and the areas of irradiated skin
were counted with a thin end-window Geiger-Mueller tube. In no instance was
there any observable contamination.
The irradiated sites were examined at 4, 8, 24, and 28 hours following appli-
cation of the plaque and thereafter at daily intervals for at least one week.
Erythema was estimated on a scale from 0 to 4 as follows:
—barely perceptible
1—easily perceptible, light intensity
2—easily perceptible, moderate intensity
3—easily perceptible, heavy intensity
4—very heavy intensity.
When pigmentation was noted it was recorded.
Observations
The observed erythema intensities for the first 28 hours are given in Table 1.
The mean of the observed erythema intensities for the 5 subjects are presented
in graphic form in Figure 3.
The erythema produced in the irradiated sites faded completely on diascopy,
and returned with release of the pressure.
After 28 hours there was a gradual admixture of pigmentation with the cry-
thema, so that by 4 days the erythema had disappeared in 3 subjects and only
faint traces remained in the other 2. The pigmentation faded gradually, lasting
TABLE 1
Observed erythema intensities in Experiment 1 with varying surface doses of P0210
Observed Erythemas
Surface Dose Time Subjects
Average
1 2 3 4 5
hrs.
55 kilorad 4 0 0 0 0 0 0
8 3 0 0 0 0 0.1
24 0 0 0 0 0.1
28 0 0 0 0 0.1
110 kilorad 4 0 0 0 0 0 0
8 1 0 1 1 0.7
24 1 0 1 1' 0.8
28 1 0 1 0.6
660 kilorad 4 1 1 1z 1', 1.2
8 3 2 2 2 1 2.2
24 3 1 2 2 1 2.0
28 3 13 2 1 1.8
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FIG. 3. The average observed erythema of the 5 subjects of Experiment 1, plotted against
time after irradiation.
up to 2 weeks, when a branny scaling occurred which lasted up to 6 weeks. No
second wave of erythema (as is often noted with conventional X-radiation) was
noted in any of the subjects.
EXPERIMENT 2
This experiment was designed to find the smallest dose of alpha radiation
from the polonium source which would produce a barely perceptible erythema.
Figure 3 suggests that erythema reaches a maximum between 8 and 20 hours
following application of the polonium plaque. Therefore, in this experiment, 7
sites were irradiated and erythema readings carried out 16 hours post-irradiation.
The surface doses were 12.5, 25, 50, 75, 100, 150, and 200 kilorad.
Observations
The observed erythema intensities with varying surface doses are presented
in Table 2, and the averages of the observed erythemas for the 5 subjects are
presented in graphic form in Figure 4.
Although there is great variability in the erythema response of human skin to
a given dose of alpha radiation, the average response of the 5 subjects gives
approximately a linear relationship between observed erythema and dose de-
livered to the surface of the skin. If this linear relationship can be extrapolated
to the axis of abscissae (representing zero erythema), that point might be con-
sidered as representing the "theoretical threshold erythema dose." * According
to Figure 4 this dose would be approximately 20 kilorad.
If the barely perceptible erythema is taken to be "h" according to our criteria,
then Figure 4 indicates that the barely perceptible erythema dose is approxi-
mately 75 kilorad.
* We have used the term "theoretical threshold erythema dose" to designate that dose
below which no erythema whatsoever would be noted, no matter how sensitive the method
of mensuration.
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Observed erythema intensities
TABLE 2





















































Fia. 4. The average observed erythema of the 5 subjects of Experiment 2, plotted against
surface dose.
EXPERIMENT 3
This experiment was designed to ascertain the relationship between the surface
dose of P0210 and time of appearance of erythema. Figure 3 suggests that erythema
appears earlier at the site receiving the larger dose, so in this experiment the
readings of erythema were made at half-hour intervals up to 8 hours post-
irradiation. The surface doses were 55, 110, and 660 kilorad.
Observations
The observed erythema intensities are presented in Tables 3 and 4, and the
averages of the observed erythema for the 5 subjects are presented in graphic
form in Figure 5. No erythema was observed with a surface dose of 55 kilorad.
These findings demonstrate that erythema appears sooner with the larger
50 100 ISO
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TABLE 3








































































































































surface dose. While the data is rather scanty, it is possible to speculate that there
is a threshold time for the appearance of erythema with each dose, and that the
erythema intensity is for a certain period roughly proportional to the elapsed
time following the appearance of the erythema. This linear increase holds only
for the first 8 hours, after which the erythema intensity levels off.
EXPERIMENT 4
This experiment was designed to determine whether or not the alpha radiation
from a polonium plaque acting at the surface of the skin is totally absorbed
within the epidermis, or whether it traverses the epidermis and bombards the
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FIG. 5. The average observed erythema of the 5 subjects of Experiment 3, plotted against
time after irradiation.
The range in tissue of the alpha particles from P0210, and (2) the thickness of the
epidermis.
1. Range of alpha particles in tissue
The depth-dose measurements in Mylar indicate that at a thickness of ap-
proximately 4.0 mg/cml the dose is only 0.001 % of the surface dose (Fig. 2).
2. Thickness of epidermis
Epidermal thickness is highly variable from one skin area to another. The
fixation of tissue makes the measurement of skin thickness difficult because of
the shrinkage of tissue volume which usually occurs. In the attempt to overcome
these difficulties in ascertaining the thickness of epidermis we carried out the
following procedure.
Procedure
The subjects were 2 of the 5 persons used in Experiment 1. Under local 2 %
procaine anesthesia a scalpel specimen for biopsy was taken from each subject
at a site adjacent to the area on the flexor aspect of the right arm which received
660 kilorad. The procaine was injected in the form of a "block" at least 2 cm
from the area to be excised in order to avoid edema of the tissue specimen. The
excised tissue was immediately frozen with carbon dioxide and sectioned on the
freezing microtome. The sections were stained with hematoxylin and eosin.
Observations
The findings are presented in Table 5.
Assuming that 1 mg/cm2 of Mylar is equivalent to a thickness of 10 of tissue,
then at a depth of 40 ,u only 0.001 % of the surface dose would remain (according
HOURS POST-IRRADIATION
208 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
TABLE 5
Thickness of epidermis from flexor aspect of arm. Measurements made from surface


































The rete pegs in each subject averaged 100—120 j in thickness.
to Fig. 2). If this assumption is correct, then the figures in the preceding table
suggest that the alpha particles delivered by the polonium plaque are in general
unable to traverse the epidermis. It is possible, however, that some penetration
may occur in a few areas where the thickness of the epidermis is less than 40
microns.
DISCUSSION AND SUMMARY
The irradiation of normal human skin from its surface has been carried out
with polonium210, a pure alpha particle emitter. The observed response of the
skin may be summarized as follows:
(1) There is a clinical biologic effect of erythema and pigmentation.
(2) The erythema fades on diascopy, indicating that it probably results from
dilatation of the superficial blood vessels of the dermis.
(3) The erythema appears within 2 to 8 hours, reaches a maximum between
8 and 20 hours, and then fades and becomes mixed with pigmentation.
(4) No second wave of erythema was observed.
(5) It may be speculated that there is a "theoretical threshold erythema dose"
for alpha radiation of about 20,000 rad.
(6) The barely perceptible erythema dose for polonium alpha radiation is
approximately 75,000 rad.
(7) The larger the dose the shorter the latent period of the appearance of
erythema.
(8) There is considerable individual variation in erythema response to polo-
nium210.
(9) Almost all of the alpha radiation from polonium215 is absorbed within the
epidermis.
(10) Many of the gross characteristics noted for the erythema produced by
polonium210 resemble closely those of ultra-violet radiation. In contrast, how-
ever, they bear little resemblance to the erythema caused by beta, gamma and x-
radiation.
The mechanism by which these highly ionizing, short trajectory alpha par-
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tides produce erythema is unknown. If our speculations are correct, and the
visible biologic effects of erythema and pigmentation are the result of irradiation
primarily of the epidermis, then the thinking regarding the biophysics of super-
ficial irradiation of the skin warrants reconsideration. For example, in order to
account for the visible erythema which results from such superficial radiation,
it might be necessary to consider the epidermal production and liberation of a
diffusable substance which in turn acts to dilate the dermal blood vessels.
It is worthy of note that although alpha radiation in the form of thorium X
has been in clinical use for over 40 years, there are no known cases of serious late
sequelae such as ulceration and the formation of malignancies. Such sequelae
are not uncommon with large doses of conventional gamma and x-radiation.
This marked difference in effect suggests that the biophysics of alpha radiation
may be fundamentally different from that of conventional X-radiation.
For these reasons, as well as others, the biologic effects of alpha radiation
applied to the surface of the human skin must receive further careful study.
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DISCUSSION
DR. MYRON H. KTJLWIN (Champaign, Ill.): I think this brings out one par-
ticular point of interest. In theory, at least, it is conceivable that any type of
radiobiologic response could be produced by any type of ionizing radiation,
provided that exposure conditions and proximity to the target substance were
suitable. The presence of erythema or any other radiobiologic effect is not a
defining characteristic of any given type of radiation. Ultimately the response
will depend on many factors, such as dose-intensity, the length of time over
which it is delivered, the size of the areas to which it is delivered, and the condi-
tion of the target substance such as its degree of hydration, temperature and
degree of oxygenation, etc.
DR. A. DoMoNoKos (New York, N. Y.): I was interested in hearing this paper
because it parallels closely the type of radiation work done with the Phillips con-
tact x-ray. Anyone who has done erythema studies will appreciate the difficulties
met in a problem like this. Previously when we talked about the threshold ery-
thema dose it was customary, using the conventional x-rays, to wait 24 to 48
hours for the appearance of erythema, but in this work and with the Phillips
contact x-ray the reaction is very prompt. It appears as early as 30 minutes.
'Whether this erythema is really a radiation effect we are not sure; it probably is
but you get a very early response in comparison to the conventional x-rays.
DR. F. KALZ (Montreal, Canada): This interesting report is the first one, to
my knowledge, dealing with the cutaneous reactions of a pure alpha emitter.
Thorium X produces chiefly alpha radiation and I have seen 2 erythema waves
resulting from exposure to this substance; it does not produce penetrating ulcers
but telangiectasis and epidermal atrophy may occur.
I would not know why no second erythema wave occurred with the polonium
plaques, it may be chiefly a question of the dosage used.
One must also keep in mind that some damage may result if very high dosage
would be used.
DR. WILLIAM S. WooD (in closing): I wish to thank the discussors. In response
to Dr. Kalz, I particularly mentioned that we had not seen late and serious
sequelae with the use of thorium X. In our observations thus far a second wave
of erythema has not been noted with polonium. Perhaps the second wave which
you have noted with thorium X was due to the beta and gamma emanations
from that substance. Finally, we do not know whether the effects of alpha radia-
tion are the same as beta and gamma radiation. It is true that on the basis of
our clinical observations, polonium irradiation closely parallels ultraviolet
radiation.
